Skip to content

SANTEL

Active
Private limited companyfounded 20215 yrs activeRue de Moncheret(ACO) 79, 6280 Gerpinnes, BelgiumKBO/BCE: BE 0762.631.519
Summary

The computed 12-month bankruptcy probability of SANTEL is 1.6% (moderate). The 2025 annual accounts show equity of €106,384 and a net result of €34,510. Equity is growing by ~30.5% per year across the filed fiscal years. Its solvency ranks better than 82% of 20110 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Risk analysisWatch ReportCompare
SANTELActiveChecked score 84/100
Risk analysis ReportCompare

Overview

What they do
Retail sale of pharmaceutical products
NACE 47730
1 site
How big
€146,637total assets 2025
Equity
€106,384
Profit
€34,510
Turnover not published (abridged schema)
Financially healthy?
84 Excellent Checked score 2025
Bankruptcy chance 12 m
1.6%
Who decides
Accounts 43 d early0 of 2 deeds read
Why 84- Limited track record- Higher-failure-rate sector- Higher-failure-rate region+ Annual accounts: healthy financial profileLatest accounts filed on timeShow the evidence

Checked score

Score 2025
84 / 100
Excellent
Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability98=
Solvency98▼-2
Growth78=
Track record94
Bankruptcy probability, 12 months
1.6% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €8,000 at 30 days acceptable
Liquidity ample (current ratio 6.11 against 9.05 in 2024; short-term debt: 12.3% and cash: 60.2% of total assets), and 27.5% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 5 years 0 10 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
72.5%
Return on assets
23.5%
Age of the figures
9 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-06-2026, 43 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
43 d early
2024
21 d early
2023
7 d late
2022
on the day
2021
4 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 11 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 31 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Annual accounts filedfiscal year 2024 · micro…
  3. Equity above €100,000Eq €111,874 ▲36.1%

Key points

  • Positive: Among the best 18% on net resultsector median €5,003 · 20,084 companies €34,510 View
  • Positive: 5 profitable years in a rowprofit 2025: €34,510 5 years View
  • Total assets 20255 fiscal years filed €146,637 View

By topic

Financials

Fiscal year
2025
Total assets
€146,637
Profit
€34,510
Solvency
72.5%
Total assets▲ 16.8%
Net result
20212025
Go to Financials

Timeline

Events
8
Since
2022
Next accounts
by 31-07-2027
  1. 18-06-2026Annual accounts filed
  2. 10-07-2025Annual accounts filed
  3. 31-12-2024Equity above €100,000
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
28-01-2021
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure